These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 19880705)

  • 1. Fallacies in the arguments for new technology: the case of proton therapy.
    Hofmann B
    J Med Ethics; 2009 Nov; 35(11):684-7. PubMed ID: 19880705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High hopes and automatic escalators: a critique of some new arguments in bioethics.
    Holm S; Takala T
    J Med Ethics; 2007 Jan; 33(1):1-4. PubMed ID: 17209100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton beam therapy and the convoluted pathway to incorporating emerging technology into routine medical care in the United States.
    Steinberg ML; Konski A
    Cancer J; 2009; 15(4):333-8. PubMed ID: 19672151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Should positive phase III clinical trial data be required before proton beam therapy is more widely adopted? No.
    Suit H; Kooy H; Trofimov A; Farr J; Munzenrider J; DeLaney T; Loeffler J; Clasie B; Safai S; Paganetti H
    Radiother Oncol; 2008 Feb; 86(2):148-53. PubMed ID: 18237800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The slippery slope and technological determinism.
    Cooper AC
    Princet J Bioeth; 1999; 2(1):64-76. PubMed ID: 11658145
    [No Abstract]   [Full Text] [Related]  

  • 6. [Conclusions. The precautionary principle: its advantages and risks].
    Tubiana M
    Bull Acad Natl Med; 2000; 184(5):969-93. PubMed ID: 11077719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human gene therapy: down the slippery slope?
    Holtug N
    Bioethics; 1993 Oct; 7(5):402-19. PubMed ID: 11656251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Slipping on slippery slope arguments.
    Fumagalli R
    Bioethics; 2020 May; 34(4):412-419. PubMed ID: 32115760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton therapy holds promise, but some call for more research.
    Printz C
    Cancer; 2009 Dec; 115(23):5363-4. PubMed ID: 19927286
    [No Abstract]   [Full Text] [Related]  

  • 10. Defending human enhancement technologies: unveiling normativity.
    de Melo-Martín I
    J Med Ethics; 2010 Aug; 36(8):483-7. PubMed ID: 20663766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A logical analysis of slippery slope arguments.
    Spielthenner G
    Health Care Anal; 2010 Jun; 18(2):148-63. PubMed ID: 19507036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A treatment planning comparison of intensity modulated photon and proton therapy for paraspinal sarcomas.
    Weber DC; Trofimov AV; Delaney TF; Bortfeld T
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1596-606. PubMed ID: 15050341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness analysis in relation to budgetary constraints and reallocative restrictions.
    Adang E; Voordijk L; Jan van der Wilt G; Ament A
    Health Policy; 2005 Oct; 74(2):146-56. PubMed ID: 16153475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case study in proton pencil-beam scanning delivery.
    Kooy HM; Clasie BM; Lu HM; Madden TM; Bentefour H; Depauw N; Adams JA; Trofimov AV; Demaret D; Delaney TF; Flanz JB
    Int J Radiat Oncol Biol Phys; 2010 Feb; 76(2):624-30. PubMed ID: 20117294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proton beam therapy - do we need the randomised trials and can we do them?
    Glimelius B; Montelius A
    Radiother Oncol; 2007 May; 83(2):105-9. PubMed ID: 17499373
    [No Abstract]   [Full Text] [Related]  

  • 16. Dosimetry of clinical neutron and proton beams: an overview of recommendations.
    Vynckier S; ;
    Radiat Prot Dosimetry; 2004; 110(1-4):565-72. PubMed ID: 15353710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The precautionary principle: advantages and risks].
    Tubiana M
    J Chir (Paris); 2001 Apr; 138(2):68-80. PubMed ID: 11319454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The origin of informed consent].
    Mallardi V
    Acta Otorhinolaryngol Ital; 2005 Oct; 25(5):312-27. PubMed ID: 16602332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contacting the brain--aspects of a technology assessment of neural implants.
    Decker M; Fleischer T
    Biotechnol J; 2008 Dec; 3(12):1502-10. PubMed ID: 19072906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implementing the Precautionary Principle: incorporating science, technology, fairness, and accountability in environmental, health, and safety decisions.
    Ashford NA
    Int J Occup Med Environ Health; 2004; 17(1):59-67. PubMed ID: 15212207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.